Professor George Warimwe works on viral infections transmitted between humans and animals in Africa, and on developing vaccines for their control.
His team developed a novel chimpanzee adenovirus-vectored vaccine against Rift Valley fever. It is highly efficacious in livestock and is now in phase 2 human clinical trials. Earlier work produced a similar One Health vaccine against MERS for use in camels and humans, and his veterinary research continues to inform advances in human vaccinology.
George is also tackling the global shortage of yellow fever vaccine through trials of fractional dosing for epidemic control. His COVID-19 serology work in Kenya informed the national pandemic response and remains one of Africa's most comprehensive seroepidemiological programmes. His team has also uncovered a high burden of chikungunya infection among children in coastal Kenya, pointing to an urgent need for vaccines that are safe for children in endemic settings.
External profile